Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris-Reference-Cited by-同舟云学术

Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris

Published:2014-04-01 Issue:1 Volume:13 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Nozue Tsuyoshi,Yamamoto Shingo,Tohyama Shinichi,Fukui Kazuki,Umezawa Shigeo,Onishi Yuko,Kunishima Tomoyuki,Sato Akira,Nozato Toshihiro,Miyake Shogo,Takeyama Youichi,Morino Yoshihiro,Yamauchi Takao,Muramatsu Toshiya,Hibi Kiyoshi,Terashima Mitsuyasu,Michishita Ichiro

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/1476-511X-13-59.pdf

Reference44 articles.

1. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, : Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005, 352: 1425-1435. 10.1056/NEJMoa050461

2. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE: Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010, 55: 2399-2407. 10.1016/j.jacc.2010.02.026

3. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P: An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001, 103: 276-283. 10.1161/01.CIR.103.2.276

4. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG: Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002, 106: 2200-2206. 10.1161/01.CIR.0000035654.18341.5E

5. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001, 104: 365-372. 10.1161/01.CIR.104.3.365

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pitavastatin Combined with Ezetimibe Treatment was an Effective Approach to Non-IRA Lesion of ST-segment Elevation Myocardial Infarction Patients with Primary Percutaneous Coronary Intervention;Current Pharmaceutical Biotechnology;2021-04-27

2. Lipoprotein(a) is associated with coronary atheroma progression: analysis from a serial coronary computed tomography angiography study;J GERIATR CARDIOL;2021

3. Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound;Journal of the American Heart Association;2020-12

4. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy;Journal of Cardiology;2020-07

5. Prognostic Value of Lipoprotein(a) Levels in Patients Undergoing Coronary Angiography for Premature Acute Coronary Syndromes;Angiology;2019-11-13